{"DataElement":{"publicId":"6483322","version":"1","preferredName":"Disease Most Recent Therapy Lymphoma Response Status","preferredDefinition":"The most recent response status to therapy for Lymphoma.","longName":"DZ_RECT_THPY_LYP_RESP_STAT","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"6483321","version":"1","preferredName":"Disease or Disorder Most Recent Therapeutic Procedure","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Greatest in amount, extent, or degree; constituting a majority._Near to or not long before the present._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","longName":"2404658v1.0:6483319v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6483319","version":"1","preferredName":"Most Recent Therapeutic Procedure","preferredDefinition":"Greatest in amount, extent, or degree; constituting a majority.:Near to or not long before the present.:An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","longName":"C25258:C25280:C49236","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Most","conceptCode":"C25258","definition":"Greatest in amount, extent, or degree; constituting a majority.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Recent","conceptCode":"C25280","definition":"Near to or not long before the present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"786DA1EB-7609-035A-E053-F662850A13A0","latestVersionIndicator":"Yes","beginDate":"2018-10-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-10-17","modifiedBy":"ONEDATA","dateModified":"2018-10-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008563","version":"1","preferredName":"Therapy Results","preferredDefinition":"the results or effects (does not include CTC Adverse Events) of therapeutic agents or procedures administered to the patient.","longName":"TX_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6690D31-4081-494A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-06","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-11","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"786DA1EB-761A-035A-E053-F662850A13A0","latestVersionIndicator":"Yes","beginDate":"2018-10-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-10-17","modifiedBy":"TAYLORT","dateModified":"2018-11-08","changeDescription":"11/8/18 TT released.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6483318","version":"1","preferredName":"Lymphoma Disease Response Status","preferredDefinition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas._The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.__A condition or state at a particular time.","longName":"6483318v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Refactory","valueDescription":"Refractory","ValueMeaning":{"publicId":"2566882","version":"1","preferredName":"Refractory","longName":"2566882","preferredDefinition":"Not responding to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Refractory","conceptCode":"C38014","definition":"Not responding to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D24F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-22","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-22","modifiedBy":"SOKKERL","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"786D8EEC-CEB8-1A47-E053-F662850AA1D0","beginDate":"2018-10-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-10-17","modifiedBy":"ONEDATA","dateModified":"2018-10-17","deletedIndicator":"No"},{"value":"Relapsed","valueDescription":"Recurrent Disease","ValueMeaning":{"publicId":"3828963","version":"1","preferredName":"Recurrent Disease","longName":"3828963","preferredDefinition":"The return of a disease after a period of remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2A8BB67-2BCE-B6D0-E040-BB89AD43093C","latestVersionIndicator":"Yes","beginDate":"2013-07-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-07-29","modifiedBy":"SOKKERL","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":"2023.1.20 Alt VM added per ticket request CADSR0001943. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"786D8EEC-CECC-1A47-E053-F662850AA1D0","beginDate":"2018-10-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-10-17","modifiedBy":"ONEDATA","dateModified":"2018-10-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6483317","version":"1","preferredName":"Lymphoma Disease Response Status","preferredDefinition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.:The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.:A condition or state at a particular time.","longName":"C3208:C50995:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"786D8EEC-CE87-1A47-E053-F662850AA1D0","latestVersionIndicator":"Yes","beginDate":"2018-10-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-10-17","modifiedBy":"ONEDATA","dateModified":"2018-10-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"786D8EEC-CE98-1A47-E053-F662850AA1D0","latestVersionIndicator":"Yes","beginDate":"2018-10-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-10-17","modifiedBy":"TAYLORT","dateModified":"2018-11-08","changeDescription":"11/8/18 TT released/PClark.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"DLBL0125","type":"OID, Theradex","context":"Theradex"}],"ReferenceDocuments":[{"name":"Response to most recent thera","type":"Preferred Question Text","description":"Response to most recent therapy","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"786C460B-8FA3-1A4F-E053-F662850A7638","latestVersionIndicator":"Yes","beginDate":"2018-10-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-10-17","modifiedBy":"SOKKERL","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}